CRS: BJMC
Position: Community Coordinator
HPTN 069 is a phase II, four-arm, multisite, randomized, double-blinded trial. To assess the safety and tolerability of four...
A5225/HiFLAC is a Phase I/II dose escalation and validation study of the safety, tolerability, and therapeutic effect of an...
The A5322 protocol is a long-term observational study, with a planned series of analyses of data to be collected from an...
This study will compare the efficacy and safety of 26 weeks of delamanid (DLM) versus 26 weeks of isoniazid (INH) for preventing...
The purpose of this study is to determine whether one or two four-month regimens of tuberculosis treatment are as effective as a...
